All News Archive

November 12, 2024

GLP-1 medicines are focus of Discovery Lecture on Nov. 21

Daniel Drucker, MD, a pioneering scientist whose research contributed to the development of the blockbuster GLP-1 medicines used to treat diabetes and obesity, was listed by TIME magazine as one of the 100 Most Influential People of 2024.

From left, Bradley Malin, PhD, Microsoft chief scientific officer Eric Horvitz, MD, PhD, and Peter Embí, MD, MS, addressed last week’s ADVANCE symposium on health care AI. (photo by Donn Jones)
November 12, 2024

Patient voices critical to success of artificial intelligence in health care

Sponsored by the Department of Biomedical Informatics, the symposium showcased the work of the department’s center for AI Discovery and Vigilance to Accelerate Innovation and Clinical Excellence.

Emma Ryleigh Dixon. (photo by Kathryn Krueger)
November 11, 2024

An inspiring legacy

Family establishes ERDie Project in memory of daughter, Emma Ryleigh Dixon, to support pediatric bone cancer research at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

November 11, 2024

Southern Environmental Health Study recruiting participants 

People who sign up can help researchers assess whether environmental factors may be the culprits behind the region’s higher cancer burden.

(iStock image)
November 11, 2024

VUMC pursues electronic integration with genomic reference labs

Under the old system, genetic counselors would complete paper requisitions, and results would return as PDFs that had to be manually uploaded into patients’ electronic health records.

(iStock image)
November 8, 2024

In-clinic reconstruction of skin cancer defects costs less than OR procedures

Researchers analyzed 1,206 patient cases and found that OR reconstruction cases had a higher median baseline cost of $2,308 compared to $987 for clinic procedures.